Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.5.4 and removed Revision: v3.5.3, indicating an update to the page's version label. This appears to be a metadata/UI update rather than a change to the study content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision tag updated to v3.5.3 from v3.5.2. This reflects a minor update to the record and does not affect the study data.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.5.2 added and v3.5.0 removed. No substantive study content appears to be affected.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3. This appears to be an internal documentation/version update and does not alter the study details or results.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The change reflects a version label update with no alterations to page content or functionality.SummaryDifference0.1%

- Check107 days agoChange DetectedAddition: Revision: v3.4.2 is now active; the previous government funding lapse notice (v3.4.1) has been removed, reflecting administrative site-wide updates rather than study data changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.